Example: dental hygienist
The List

The List

Back to document page

another strong catalyst for Kaleido’s share price. The next therapy in Kaleido’s pipeline is KB195 for hyperammonemia. This is a dangerous blood disorder that can lead to brain injury. Hyperammonemia is a lesser-known condition, but it’s a big problem. In fact, the global market for treatments is expected to reach $76.6 billion by 2025.

  Lists, Recip

Download The List


Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Other abuse

Advertisement

Related search queries